Diartis Pharmaceuticals, Inc. is a privately held biopharmaceutical company with headquarters in Mountain View, CA. Diartis Pharmaceuticals was formed to concentrate on the development of novel therapeutic proteins for the treatment of metabolic disorders. In December 2010, Diartis Pharmaceuticals acquired the VRS-859 program from Versartis, Inc.
Funding Rounds (1) - undisclosedUpdate
Current Team (1)Update
Board Members and Advisors (1)Update
|Feb 18, 2016||PRNewswire UK All - Peptide Therapeutics in Metabolic Disordersto 2025 - Metabolic Disorders Have Gained Significant Attention for the Development of Peptide Based Therapies|
|Feb 16, 2011||FinSMEs - FinSMEs|
500 Ellis Street
Mountain View, CA 94043